Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Nanoliposomes as drug delivery systems: safety concerns.

Autor: Tereshkina, Yu. A., Torkhovskaya, T. I., Tikhonova, E. G., Kostryukova, L. V., Sanzhakov, M. A., Korotkevich, E. I., Khudoklinova, Yu. Yu., Orlova, N. A., Kolesanova, E. F.

Publikováno v: Journal of Drug Targeting; Mar 2022, Vol. 30 Issue 3, p313-325, 13p

[The effect of lipid derivative of anti-tumor drug sarcolysin embedded in phospholipid nanoparticles in the experiments in vivo].

Autor: Tereshkina YA; Institute of Biomedical Chemistry, Moscow, Russia., Torkhovskaya TI; Institute of Biomedical Chemistry, Moscow, Russia., Sanzhakov MA; Institute of Biomedical Chemistry, Moscow, Russia., Kostryukova LV; Institute of Biomedical Chemistry, Moscow, Russia., Khudoklinova YY; Institute of Biomedical Chemistry, Moscow, Russia., Tikhonova EG; Institute of Biomedical Chemistry, Moscow, Russia.

Publikováno v: Biomeditsinskaia khimiia [Biomed Khim] 2021 Nov; Vol. 67 (6), pp. 491-499.

[Influence of resveratrol and dihydroquercetin inclusion into phospholipid nanopatricles on their bioavailability and specific activity].

Autor: Guseva DA; Moscow State University of Technologies and Management, Moscow, Russia., Khudoklinova YY; IBMC - EcoBioPharm LLC, Moscow, Russia., Medvedeva NV; Institute of Biomedical Chemistry, Moscow, Russia., Baranova VS; Institute of Biomedical Chemistry, Moscow, Russia., Zakharova TS; Institute of Biomedical Chemistry, Moscow, Russia., Artyushkova EB; Kursk State Medical University, Kursk, Russia., Torkhovskaya TI; Institute of Biomedical Chemistry, Moscow, Russia., Ipatova OM; Institute of Biomedical Chemistry, Moscow, Russia.

Publikováno v: Biomeditsinskaia khimiia [Biomed Khim] 2015 Sep-Oct; Vol. 61 (5), pp. 598-605.